Portola Pharmaceuticals
IPONovel therapeutics for cardiovascular and autoimmune diseases
South San Francisco, United States · Founded 2003 · $216.0M raised
- Headquarters
- South San Francisco, California
- Founded
- 2003
- Business Model
- B2B
- Website
- portola.com
- Total Funding
- $216.0M
- Last Round
- $89.0M Venture RoundNov 2011
- Rounds
- 4
About
Portola Pharmaceuticals was a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for patients with acute and chronic cardiovascular, autoimmune, and inflammatory diseases. The company's lead programs centered on anticoagulation and thrombosis, with its most notable product being Andexxa (andexanet alfa), the first approved antidote for reversal of Factor Xa inhibitors including rivaroxaban and apixaban. Portola also developed Bevyxxa (betrixaban), a Factor Xa inhibitor approved for VTE prophylaxis. The company was founded by Charles J. Homcy and David Phillips and was headquartered in South San Francisco, California. Portola was acquired by Alexion Pharmaceuticals in 2020, and portola.com now redirects to the Alexion website.
Summary
Portola Pharmaceuticals is a Biotech company based in South San Francisco, United States, founded in 2003. It has raised $216.0M in total across 4 rounds, most recently a $89.0M Venture Round round in Nov 2011. Investors include Temasek, Eastern Advisors and D. E. Shaw group.
Tech & App Stack
3 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
May 2020
Sign up to see all 5 rounds
Venture Round through Acquisition — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Specialty pharmaceutical company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/portola-pharmaceuticals"><img src="https://indexed.vc/api/badge/company/portola-pharmaceuticals" alt="Portola Pharmaceuticals on Indexed.vc" width="260" height="76" /></a>